Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC and Vitamin D for Corrosive Ingestion in Children
NCT07229456Phase 3Active, not recruiting
- Sponsor
- Ain Shams University
- Start
- Oct 2024
- Primary completion
- Oct 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of acetylcysteine and vitamin d in corrosive esophagitis (4 arms), sponsored by Ain Shams University. Primary endpoint: Incidence of stricture formation at 21 days. Started Oct 2024; status: active, not recruiting.
02
Drugs
acetylcysteinevitamin d
03
Conditions
corrosive esophagitis
Beyond the preview
Go deeper on NCT07229456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07229456.